187 related articles for article (PubMed ID: 16113598)
1. Predicting response to interleukin-2 therapy among patients with renal cell carcinoma.
Leppert JT; Lam JS; Belldegrun AS
J Immunother; 2005; 28(5):427-9. PubMed ID: 16113598
[No Abstract] [Full Text] [Related]
2. Renal cell carcinoma and interleukin-2: what are the endpoints?
Figlin RA
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S68-9. PubMed ID: 9457397
[No Abstract] [Full Text] [Related]
3. Metastatic renal cell carcinoma: systemic treatment.
Abi-Aad AS; deKernion JB
Acta Urol Belg; 1996 May; 64(2):3-8. PubMed ID: 8701805
[No Abstract] [Full Text] [Related]
4. Renal cell cancer: is immunotherapy dead?
Wagstaff J
Ann Oncol; 2007 Jul; 18 Suppl 9():ix94-7. PubMed ID: 17631604
[No Abstract] [Full Text] [Related]
5. Immunotherapy for renal cell carcinoma.
Rosenblatt J; McDermott DF
Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
[TBL] [Abstract][Full Text] [Related]
6. Reduction of brain metastasis following immunotherapy with interleukin-2 for stage IV renal cell cancer.
Citterio G; Di Lucca G; Scaglietti U; Gilberti S; Baldini M; Rugarli C
Acta Oncol; 1997; 36(2):228. PubMed ID: 9140444
[No Abstract] [Full Text] [Related]
7. Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.
NĂ©grier S
J Clin Oncol; 2004 Apr; 22(7):1174-6. PubMed ID: 14981101
[No Abstract] [Full Text] [Related]
8. Eosinophilia induced by interleukin-2 cancer immunotherapy may be associated with enhanced production of total IgE.
Vecchi L; Lissoni P
Int J Biol Markers; 1995; 10(1):59-60. PubMed ID: 7629429
[No Abstract] [Full Text] [Related]
9. Immunotherapy for metastatic renal cell carcinoma.
McDermott DF; Rini BI
BJU Int; 2007 May; 99(5 Pt B):1282-8. PubMed ID: 17441925
[No Abstract] [Full Text] [Related]
10. Update on the application of interleukin-2 in the treatment of renal cell carcinoma.
McDermott DF
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):716s-720s. PubMed ID: 17255299
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment.
Taneja SS; Pierce W; Figlin R; Belldegrun A
Urology; 1995 Jun; 45(6):911-24. PubMed ID: 7771023
[No Abstract] [Full Text] [Related]
12. Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy.
Upton MP; Parker RA; Youmans A; McDermott DF; Atkins MB
J Immunother; 2005; 28(5):488-95. PubMed ID: 16113605
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Immunotherapy for advanced renal cell cancer.
Coppin C; Porzsolt F; Autenrieth M; Kumpf J; Coldman A; Wilt TJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD001425. PubMed ID: 26713838
[TBL] [Abstract][Full Text] [Related]
14. Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
Figlin RA; Pierce WC; Belldegrun A
Semin Oncol; 1993 Dec; 20(6 Suppl 9):11-5. PubMed ID: 8284686
[No Abstract] [Full Text] [Related]
15. Recent advances in immunotherapy for kidney cancer.
Ball MW; Allaf ME; Drake CG
Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
[TBL] [Abstract][Full Text] [Related]
16. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
Pandha H
Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
[No Abstract] [Full Text] [Related]
17. Immunotherapy of renal cell carcinoma.
Haas GP; Hillman GG; Redman BG; Pontes JE
CA Cancer J Clin; 1993; 43(3):177-87. PubMed ID: 8490757
[TBL] [Abstract][Full Text] [Related]
18. Sarcomatoid renal cell carcinoma.
Akhtar K; Shamshad A; Sufian Z; Tariq M
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):120-2. PubMed ID: 21196626
[TBL] [Abstract][Full Text] [Related]
19. Emerging immunotherapy in advanced renal cell carcinoma.
Mendiratta P; Rini BI; Ornstein MC
Urol Oncol; 2017 Dec; 35(12):687-693. PubMed ID: 28889919
[TBL] [Abstract][Full Text] [Related]
20. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma.
Pantuck AJ; Belldegrun AS; Figlin RA
N Engl J Med; 2001 Dec; 345(23):1711-2. PubMed ID: 11759660
[No Abstract] [Full Text] [Related]
[Next] [New Search]